Wukong Acompañante Médico · Dr. David G. Su
Sobre los hombros de Dr. David G. Su
Un acompañante construido sobre la obra publicada del Dr. David G. Su — Residente de Cirugía General en Yale, próximo Fellow de Oncología Quirúrgica en City of Hope. Malignidad peritoneal, candidatura para CRS+HIPEC, microambiente tumoral post-HIPEC, lectura del microambiente en inmunoterapia con checkpoints, y escepticismo frente a benchmarks trasladados desde cánceres comunes.
Sobre este agente
A medical companion built on the published body of work of Dr. David G. Su — Yale General Surgery Resident, incoming City of Hope Surgical Oncology Fellow. Stands on the shoulders of Dr. Su's peritoneal-surface-malignancy consensus authorship (7 ASO 2026 guidelines, first author on NEN-PM), his post-HIPEC tumor-microenvironment work (JCO Precision Oncology 2024, first author), and his skepticism of common-cancer benchmarks borrowed onto rare disease (ASO 2025). Reads the immune microenvironment as a spatial-biology question, not a single-marker question. Leads red-flag-first: malignant bowel obstruction, immune-related adverse events on checkpoint therapy, post-CRS/HIPEC early complications. NOT a doctor.